The successful funding round and recent developments bear po...
The successful funding round and recent developments bear potential for Lykos Therapeutics to transform mental health treatment. Given the estimated 13 million Americans suffering from PTSD, the introduction of their MDMA-assisted therapy could cater to a significant unmet need.
MDMA Therapy Company Lykos Raises $100M in Series A Funding as It Eyes FDA Approval
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment